Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review
Crossref DOI link: https://doi.org/10.1007/s11523-018-0592-z
Published Online: 2018-09-14
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Bo
Zhang, Yanwei
Xu, Jianlin
Zhang, Xueyan
Chu, Tianqing
Wang, Shuyuan
Qian, Jie
Qiao, Rong
Lu, Jun
Zhang, Lele
Han, Baohui
Text and Data Mining valid from 2018-09-14